Currently, the analyst consensus on CVS Health is a Strong Buy with an average price target of $96.33, implying a 31.45% upside from current levels. In a report released yesterday, TD Cowen also ...

U.S. health insurers have made it easier for doctors to get approval before providing certain types of treatment, industry ...

Opinion: Every day without reform of the prescription-drug system means higher prices, fewer choices and deeper strain on ...

Moby BREAKING NEWS. The health insurance lobby has been living rent-free inside Washington's head for years, and on Monda ...

Last summer, the insurance industry broadly agreed to reform a major healthcare pain point: prior authorization. | Last ...

As independent practices buckle under rising costs, administrative burdens and stagnant reimbursement, a new and unlikely cast of acquirers has entered the game, moving beyond the traditional hospital ...

Bernstein analyst Lance Wilkes maintained a Buy rating on Cigna yesterday and set a price target of $358.00. Wilkes covers the Healthcare sector, focusing on stocks such as Cigna, Centene, and CVS ...

Everyone loves a comeback story, right? Well, maybe not in this case. I am not taking sides regarding the social debate and ...

These five healthcare stocks were up after the Centers for Medicare & Medicaid Services' announcement of a large increase in the expected Medicare Advantage reimbursement rate for 2027. For Centene ...

Early on Monday, the hottest stocks in the S&P 500 based on premarket trading were all in the healthcare sector and managed care providers were dominating. These were the five best performers among ...

Anthropic, the artificial intelligence company that recently fought the Pentagon over the use of its technology, has built a ...

Sens. Bernie Sanders (I-Vt.) and Ron Wyden (D-Ore.) are calling on Republican committee leaders to hold hearings with the ...